Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01D
- Chemical subgroupL01DA
- Chemical substanceL01DA01Dactinomycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 5 registrations
- CosmegenLaboratórios Bagó do Brasil S/A
- CosmegenProdome Química e Farmacêutica Ltda
- CosmegenOrganon Farmacêutica Ltda.
- DactinLaboratorio Itafarma Ltda
New Zealand
PHARMAC (NZ funding schedule) · 2 registrations
United States
FDA · 2 registrations
At a glance
- ATC code
- L01DA01
- Registers
- 5
- Registrations
- 11
- With their own page
- 6
- Companies
- 9
All medicines with Dactinomycin
Human medicines from every register that match Dactinomycin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
11 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dactinomycin | United States | 0.5MG/VIAL | injectable | Marketed | Hikma |
| K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vial | Singapore | 0.5 mg/vial | injection, powder, for solution | Authorised | Shoei Universal Corporation Pte LTD |
| Cosmegen | United States | 0.5MG/VIAL | injectable | Not marketed | Recordati Rare |
| Cosmegen | Canada | 0.5 MG / VIAL | Powder For Solution | Marketed | Recordati Rare Diseases Canada INC |
| Baxter | New Zealand | Inj 0.5 mg for ECP | Funded | ||
| Cosmegen | New Zealand | Inj 0.5 mg vial | Funded | ||
| K. U . Dactinomycin | Brazil | Cancelled | Ucb Biopharma Ltda. | ||
| Dactin | Brazil | Cancelled | Laboratorio Itafarma Ltda | ||
| Cosmegen | Brazil | Cancelled | Prodome Química e Farmacêutica Ltda | ||
| Cosmegen | Brazil | Cancelled | Laboratórios Bagó do Brasil S/A | ||
| Cosmegen | Brazil | Cancelled | Organon Farmacêutica Ltda. |